Fundraising Fox
/Companies
Sign in

myNEO Therapeutics

Founded 2018 · 18 employees on LinkedIn · 1 known investors

Find your way into myNEO Therapeutics

Sign up to see every warm intro you have to myNEO Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the myNEO Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs. The company serves pharmaceutical and biotech organizations across target discovery, optimization, and data analysis stages.

AI & Machine LearningBiotechHealthtechSaaS

Founders & leadership

Board

CBCedric Bogaert
Cedric BogaertEntrepreneur in Residence - managing myNEO at Novalis Biotech
JVJan Van Den Berghe
Jan Van Den BergheCo-Founder / Managing Director at Novalis Biotech
WVWim van Criekinge
Wim van CriekingeCo-Founder / Managing Director at Novalis Biotech

Investors · 1

Frequently asked questions

What does myNEO Therapeutics do?
myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs. The company serves pharmaceutical and biotech organizations across target discovery, optimization, and data analysis stages.
Who are myNEO Therapeutics's investors?
myNEO Therapeutics's investors include Novalis Biotech.